The average length of stay for dermatitis, eczema, and papulosquamous disorders in France remains stable from 2024 to 2026 at 6.4 days, with a slight reduction to 6.3 days in 2027 and 2028. This forecasted stability suggests there were no dramatic changes in medical practices or patient care efficiency compared to last year’s figure, which stood at 6.4 days in 2023.
- Year-on-year stability with a decrease of approximately 1.56% for 2027 and 2028.
- Once decreased from 6.4 to 6.3 days, maintaining it rather than reducing again is noteworthy.
Future trends to watch include advancements in outpatient care and telemedicine, which might influence hospital stays by further reducing the necessity for inpatient treatment in dermatology, improving overall patient management, and possibly decreasing the average length of stay.
